Teva Says Mylan Is Just Unhappy About MS Drug Competition
Teva Pharmaceuticals has urged a New Jersey federal court to toss Mylan's lawsuit accusing the generic-drug giant of an illegal scheme to stifle competition with its multiple sclerosis treatment, arguing that...To view the full article, register now.
Already a subscriber? Click here to view full article